Matches in SemOpenAlex for { <https://semopenalex.org/work/W4385851346> ?p ?o ?g. }
- W4385851346 endingPage "3264" @default.
- W4385851346 startingPage "3249" @default.
- W4385851346 abstract "The brain-derived neurotrophic factor (BDNF)/TrkB pathway plays a crucial role in neural plasticity and neuronal survival but is often deficient in neurodegenerative diseases like Alzheimer’s disease (AD). CF3CN acts as a specific TrkB agonist that displays therapeutic effects in the AD mouse model, but its brain/plasma ratio (B/P ratio) distribution is not satisfactory. To increase its brain exposure, we synthesized several derivatives and employed nanoparticle (NP) formulation to optimize the most potent #2 derivative’s in vivo PK profiles. We generated stable #2-loaded zein/lactoferrin composite NPs (#2/zein/LF) using the antisolvent co-precipitation method. In vivo PK studies revealed that nanoencapsulation improved #2’s oral bioavailability by approximately 2-fold and significantly enhanced its plasma Cmax and t1/2, but the brain profiles were comparable. Pharmacodynamics showed that #2/zein/LF activates TrkB signaling that phosphorylates asparagine endopeptidase (AEP) T322 and decreases its enzymatic activity, resulting in reduced AEP-cleaved amyloid precursor protein and Tau fragments in the brains of AD mice, correlating with its PK profiles. After 3 months of treatment in 3xTg mice, #2/zein/LF decreased AD pathologies and alleviated cognitive dysfunction. Hence, zein/LF composite nanoencapsulation is a promising drug delivery method for improving the PK profiles of a potential preclinical candidate for treating neurodegenerative diseases." @default.
- W4385851346 created "2023-08-17" @default.
- W4385851346 creator A5016688487 @default.
- W4385851346 creator A5028324966 @default.
- W4385851346 creator A5050751602 @default.
- W4385851346 creator A5062924912 @default.
- W4385851346 creator A5065046570 @default.
- W4385851346 creator A5070887856 @default.
- W4385851346 creator A5073266870 @default.
- W4385851346 creator A5084974862 @default.
- W4385851346 date "2023-08-16" @default.
- W4385851346 modified "2023-10-14" @default.
- W4385851346 title "Zein-Based Nanoparticles Improve the Therapeutic Efficacy of a TrkB Agonist toward Alzheimer’s Disease" @default.
- W4385851346 cites W1747414752 @default.
- W4385851346 cites W1935732933 @default.
- W4385851346 cites W1965571382 @default.
- W4385851346 cites W1967316112 @default.
- W4385851346 cites W1971263143 @default.
- W4385851346 cites W1971492868 @default.
- W4385851346 cites W1973486900 @default.
- W4385851346 cites W1980087265 @default.
- W4385851346 cites W1981782246 @default.
- W4385851346 cites W1985004872 @default.
- W4385851346 cites W1990703828 @default.
- W4385851346 cites W1992037149 @default.
- W4385851346 cites W1992230271 @default.
- W4385851346 cites W1993760429 @default.
- W4385851346 cites W2006733352 @default.
- W4385851346 cites W2011068615 @default.
- W4385851346 cites W2021378654 @default.
- W4385851346 cites W2022485771 @default.
- W4385851346 cites W2026077861 @default.
- W4385851346 cites W2041285433 @default.
- W4385851346 cites W2042600422 @default.
- W4385851346 cites W2055979394 @default.
- W4385851346 cites W2066110504 @default.
- W4385851346 cites W2067155791 @default.
- W4385851346 cites W2073644964 @default.
- W4385851346 cites W2087672059 @default.
- W4385851346 cites W2100901337 @default.
- W4385851346 cites W2109078751 @default.
- W4385851346 cites W2110341145 @default.
- W4385851346 cites W2119184935 @default.
- W4385851346 cites W2131545168 @default.
- W4385851346 cites W2138944326 @default.
- W4385851346 cites W2151986987 @default.
- W4385851346 cites W2154727263 @default.
- W4385851346 cites W2192805543 @default.
- W4385851346 cites W2315782077 @default.
- W4385851346 cites W2331604785 @default.
- W4385851346 cites W2415859941 @default.
- W4385851346 cites W2614773512 @default.
- W4385851346 cites W2791036967 @default.
- W4385851346 cites W2803674762 @default.
- W4385851346 cites W2809605052 @default.
- W4385851346 cites W2888065392 @default.
- W4385851346 cites W2914005116 @default.
- W4385851346 cites W2917531660 @default.
- W4385851346 cites W2997612646 @default.
- W4385851346 cites W3012845890 @default.
- W4385851346 cites W3130378078 @default.
- W4385851346 cites W3134681585 @default.
- W4385851346 cites W3158894317 @default.
- W4385851346 cites W3162484413 @default.
- W4385851346 cites W3168942664 @default.
- W4385851346 cites W3193178485 @default.
- W4385851346 cites W3199650262 @default.
- W4385851346 cites W4205460733 @default.
- W4385851346 cites W4281609763 @default.
- W4385851346 cites W4293156776 @default.
- W4385851346 cites W4318814750 @default.
- W4385851346 cites W561956948 @default.
- W4385851346 doi "https://doi.org/10.1021/acschemneuro.3c00401" @default.
- W4385851346 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37583253" @default.
- W4385851346 hasPublicationYear "2023" @default.
- W4385851346 type Work @default.
- W4385851346 citedByCount "0" @default.
- W4385851346 crossrefType "journal-article" @default.
- W4385851346 hasAuthorship W4385851346A5016688487 @default.
- W4385851346 hasAuthorship W4385851346A5028324966 @default.
- W4385851346 hasAuthorship W4385851346A5050751602 @default.
- W4385851346 hasAuthorship W4385851346A5062924912 @default.
- W4385851346 hasAuthorship W4385851346A5065046570 @default.
- W4385851346 hasAuthorship W4385851346A5070887856 @default.
- W4385851346 hasAuthorship W4385851346A5073266870 @default.
- W4385851346 hasAuthorship W4385851346A5084974862 @default.
- W4385851346 hasConcept C126322002 @default.
- W4385851346 hasConcept C150903083 @default.
- W4385851346 hasConcept C160539049 @default.
- W4385851346 hasConcept C170493617 @default.
- W4385851346 hasConcept C185592680 @default.
- W4385851346 hasConcept C207001950 @default.
- W4385851346 hasConcept C25498285 @default.
- W4385851346 hasConcept C2778790584 @default.
- W4385851346 hasConcept C2778938600 @default.
- W4385851346 hasConcept C2779134260 @default.
- W4385851346 hasConcept C2779483572 @default.
- W4385851346 hasConcept C2984863031 @default.